Portfolio company
Themis Bioscience
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops vaccines and immune-modulation therapies for infectious diseases and cancer to protect human populations from unmet medical needs.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Nykode Therapeutics
This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.
Vaccitech Ltd
This biopharmaceutical company develops immunotherapeutic products and vaccines for patients with chronic infectious diseases, autoimmune conditions and cancer.
IO Biotech
The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.
Thymmune
This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.
Nykode
Nykode develops immunotherapy and vaccines for cancer and infectious diseases, targeting pharmaceutical companies through partnerships and licensing agreements.
Abacus Bioscience
This company develops active immunotherapies to treat cancer and chronic infections for patients requiring advanced medical treatments.
Cytos Biotechnology AG
This biopharmaceutical company develops immunotherapies and vaccines targeting chronic and infectious diseases for patients and healthcare providers.
Pharmexa A/S
This company develops active immunotherapy and peptide vaccines for patients with cancer, chronic illnesses, and infectious diseases.
